Raffaele Ornello

Nov 29, 2024 | nature.com | Matteo Foschi |Raffaele Ornello |Federico De Santis |Michele Romoli |Federica De Santis |Francesca Gabriele | +1 more

AbstractThe use of antiplatelet therapy (APT) is prevalent among the general population, sometimes without clear indications. We provided updated figures on the incidence and prognosis of first-ever intracerebral hemorrhage occurring on APT (APT-ICH) over 10 years in a population-based stroke registry and investigated the rates of inappropriate APT prescription.

Oct 27, 2023 | frontiersin.org | Tim Jürgens |Raffaele Ornello

1. Introduction Chronic migraine involves multiple signaling pathways activated by the release of vasoactive peptides from trigeminovascular neurons (1). For migraine prevention, onabotulinumtoxin A and calcitonin gene-related peptide (CGRP) antagonists are effective and well tolerated therapies.

May 22, 2023 | n.neurology.org | Raffaele Ornello |Luciano A. Sposato |Simona Sacco

REQUIREMENTSYou must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information. Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.